This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
CLS1 Aperçu des actions
McKesson Europe AG provides logistics and other services to the pharmaceutical and healthcare sectors worldwide.
| Score flocon de neige | |
|---|---|
| Évaluation | 1/6 |
| Croissance future | 0/6 |
| Performances passées | 0/6 |
| Santé financière | 5/6 |
| Dividendes | 1/6 |
Récompenses
Analyse des risques
McKesson Europe AG Concurrents
Historique des prix et performances
| Historique des cours de bourse | |
|---|---|
| Prix actuel de l'action | €24.40 |
| Plus haut sur 52 semaines | €24.50 |
| Plus bas sur 52 semaines | €19.80 |
| Bêta | 0.13 |
| 1Variation sur 1 mois | 0.83% |
| Variation sur 3 mois | 0.83% |
| Variation sur 1 an | 9.91% |
| 3Variation sur 3 ans | -6.51% |
| Variation sur 5 ans | -7.58% |
| Évolution depuis l'introduction en bourse | -6.51% |
Nouvelles et mises à jour récentes
Estimating The Fair Value Of McKesson Europe AG (HMSE:CLS1)
Dec 23
These Return Metrics Don't Make McKesson Europe (HMSE:CLS1) Look Too Strong
Sep 01Recent updates
Estimating The Fair Value Of McKesson Europe AG (HMSE:CLS1)
Dec 23These Return Metrics Don't Make McKesson Europe (HMSE:CLS1) Look Too Strong
Sep 01These Return Metrics Don't Make McKesson Europe (HMSE:CLS1) Look Too Strong
May 19McKesson Europe (HMSE:CLS1) Could Be Struggling To Allocate Capital
Jan 27Capital Allocation Trends At McKesson Europe (HMSE:CLS1) Aren't Ideal
Sep 07McKesson Europe (HMSE:CLS1) Will Be Looking To Turn Around Its Returns
Apr 29What You Need To Know About McKesson Europe AG's (HMSE:CLS1) Investor Composition
Mar 20Is McKesson Europe AG (HMSE:CLS1) A Risky Dividend Stock?
Feb 13
Rendement pour les actionnaires
| CLS1 | DE Healthcare | DE Marché | |
|---|---|---|---|
| 7D | 0% | -1.9% | -1.8% |
| 1Y | 9.9% | 24.7% | 13.6% |
Rendement vs Industrie: CLS1 exceeded the German Healthcare industry which returned -12.8% over the past year.
Rendement vs marché: CLS1 exceeded the German Market which returned 1.4% over the past year.
Volatilité des prix
| CLS1 volatility | |
|---|---|
| CLS1 Average Weekly Movement | 0.7% |
| Healthcare Industry Average Movement | 3.7% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 11.5% |
| 10% least volatile stocks in DE Market | 2.4% |
Cours de l'action stable: CLS1 has not had significant price volatility in the past 3 months.
Volatilité au fil du temps: CLS1's weekly volatility (1%) has been stable over the past year.
À propos de l'entreprise
| Fondée | Salariés | PDG | Site web |
|---|---|---|---|
| 1835 | 6,808 | Sebastian Ring | www.mckesson.eu/mck-en |
McKesson Europe AG Résumé des fondamentaux
| CLS1 statistiques fondamentales | |
|---|---|
| Capitalisation boursière | €4.96b |
| Bénéfices(TTM) | -€54.30m |
| Recettes(TTM) | €9.26b |
0.5x
Ratio P/S-91.3x
Ratio P/ELe site CLS1 est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
| CLS1 compte de résultat (TTM) | |
|---|---|
| Recettes | €9.26b |
| Coût des recettes | €8.46b |
| Marge brute | €792.30m |
| Autres dépenses | €846.60m |
| Les revenus | -€54.30m |
Derniers bénéfices déclarés
Mar 31, 2022
Prochaine date de publication des résultats
s/o
| Résultat par action (EPS) | -0.27 |
| Marge brute | 8.56% |
| Marge bénéficiaire nette | -0.59% |
| Ratio dettes/capitaux propres | 0.3% |
Quelles ont été les performances à long terme de CLS1?
Voir les performances historiques et les comparaisons